Rallybio
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Rallybio generated cash of -$60,265,000, which is less than the previous year. Cash used in financing activities reached the amount of $143,000 last year. Net change in cash is therefore -$32,464,000.

Cash Flow

Rallybio Corporation (NASDAQ:RLYB): Cash Flow
2019 -15.02M -188K 31.56M
2020 -22.03M -2.07M 144.88M
2021 -45.53M -2.33M 82.96M
2022 -57.28M -112.17M 51.07M
2023 -60.26M 27.65M 143K

RLYB Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
56.95M175.33M140.23M19.45M3.10M
Operating activities
Net income
-74.56M-66.65M-47.01M-26.44M-17.56M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
150K167K109K62K26K
Stock-based compensation expense
10.92M9.49M3.64M704K194K
Deferred income tax benefit 10.92M9.49M3.64M704K194K
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
-99K487K-976K723K728K
Cash generated by operating activities
-60.26M-57.28M-45.53M-22.03M-15.02M
Investing activities
Purchases Of Investments
-110.66M-201.31M-2M-1.93M0
Investments In Property Plant And Equipment
-12K-54K-333K-137K-188K
Acquisitions Net
-2.25M-300K-2M-1.93M0
Cash generated by investing activities
27.65M-112.17M-2.33M-2.07M-188K
Financing activities
Common Stock Issued
143K51.53M86.2M145.20M31.6M
Payments for dividends
00000
Repurchases of common stock
282K0000
Repayments of term debt
00000
Cash used in financing activities
143K51.07M82.96M144.88M31.56M
Net Change In Cash
-32.46M-118.37M35.10M120.77M16.35M
Cash at end of period
24.49M56.95M175.33M140.23M19.45M
Data sourceData sourceData source